CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
20 hedge funds and large institutions have $8.89M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.
Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SWM
1
SeaCrest Wealth Management
Purchase,
New York
|
$409K |
2 |
2
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$539K |
3 |
3
Jane Street
New York
|
$348K |
4 |
BL
4
BCWM LLC
Overland Park,
Kansas
|
$4.61M |
5 |
5
Citigroup
New York
|
$242K |